ARK Investment Management LLC
Institutional investor · Portfolio as of Q2 2020
Top Holdings213 positions
TESLA INC | 712,348 | $769.2M | 8.3% | $27.25 | +164.21% | 7 qtrssince 2018-Q4 | Increased 73 |
INVITAE CORP | 23.8M | $721.5M | 7.8% | — | — | 7 qtrssince 2018-Q4 | Increased 84 |
BLOCK INC | 6M | $633.4M | 6.8% | $67.77 | +52.99% | 7 qtrssince 2018-Q4 | Increased 76 |
CRISPR THERAPEUTICS AG | 6.5M | $476.5M | 5.1% | $50.39 | +45.85% | 7 qtrssince 2018-Q4 | Increased 85 |
ROKU INC | 3.3M | $387.2M | 4.2% | $108.47 | +6.07% | 5 qtrssince 2019-Q2 | Increased 91 |
2U INC | 9.6M | $365.3M | 3.9% | — | — | 7 qtrssince 2018-Q4 | Increased 76 |
ILLUMINA INC | 928,537 | $343.9M | 3.7% | $292.47 | +23.18% | 7 qtrssince 2018-Q4 | Decreased 0 |
ZILLOW GROUP INC | 5M | $289.3M | 3.1% | $47.18 | -36.70% | 3 qtrssince 2019-Q4 | Increased 79 |
LENDINGTREE INC NEW | 940,694 | $272.4M | 2.9% | $257.03 | +6.12% | 7 qtrssince 2018-Q4 | Increased 85 |
PROTO LABS INC | 2.2M | $249.3M | 2.7% | $97.78 | +17.08% | 7 qtrssince 2018-Q4 | Increased 69 |
INTELLIA THERAPEUTICS INC | 11.4M | $239.7M | 2.6% | $14.65 | +43.47% | 7 qtrssince 2018-Q4 | Increased 59 |
EDITAS MEDICINE INC | 7.5M | $223.2M | 2.4% | $24.03 | +22.10% | 7 qtrssince 2018-Q4 | Increased 70 |
COMPUGEN LTD | 14.1M | $211.8M | 2.3% | $6.24 | +125.13% | 7 qtrssince 2018-Q4 | Increased 68 |
XILINX INC | 2.1M | $205.6M | 2.2% | — | — | 7 qtrssince 2018-Q4 | Increased 68 |
SPLUNK INC | 980,624 | $194.9M | 2.1% | — | — | 7 qtrssince 2018-Q4 | Increased 66 |
PURE STORAGE INC | 11.1M | $192.6M | 2.1% | $15.38 | +12.71% | 2 qtrssince 2020-Q1 | Increased 84 |
STRATASYS LTD | 11.3M | $179.1M | 1.9% | $18.40 | -14.56% | 7 qtrssince 2018-Q4 | Increased 55 |
PINTEREST INC | 7.6M | $167.7M | 1.8% | $17.86 | +23.43% | 4 qtrssince 2019-Q3 | Increased 62 |
PAGERDUTY INC | 5.2M | $148.8M | 1.6% | $19.75 | +41.80% | 2 qtrssince 2020-Q1 | Increased 77 |
TERADYNE INC | 1.8M | $148.2M | 1.6% | $61.91 | +33.34% | 7 qtrssince 2018-Q4 | Increased 77 |
ARK Investment Management LLC manages $9.3B across 213 positions as of Q2 2020. Top holdings: TSLA (8.3%), NVTAQ (7.8%), XYZ (6.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 16 new positions, 10 exits, 176 increased. Top move: ROKU (INCREASED, conviction 91). Portfolio: $9.3B across 213 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR